RE:RE:WhenDid some digging and came up empty.
Jan 15 trading starts yes, but zero indication who is and who is not. I would have expected that information to flow ahead of time for investors to make decisions on if they like the basket or not....
Admin fees will be as high relative to other ETFs as their cannabis one as the risk is high.
I am not a huge fan of the ETF as a whole as I think it will move, but I prefer pinpointing a couple companies I like more than the others. Similar to canna, many of the shroom comps are fluffballs.
This is a winner tough overall, but the gains nowhere near what I think TRIP can acheive immediate, short, mid and long term.
Canna one did well, but not moonshotta
DonnyTrumpets...any opinion here?